Literature DB >> 17600273

Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury.

Mario Perl1, Chun-Shiang Chung, Ulrike Perl, Joanne Lomas-Neira, Monique de Paepe, William G Cioffi, Alfred Ayala.   

Abstract

RATIONALE: Indirect acute lung injury (ALI) is associated with high morbidity and mortality. No specific therapies have been developed, because the underlying pathophysiological processes remain elusive.
OBJECTIVES: To investigate the contribution of Fas-induced apoptotic and nonapoptotic/inflammatory signaling to the pathology of indirect ALI.
METHODS: A mouse model of indirect ALI, induced by successive exposure to hemorrhagic shock and cecal ligation and puncture, was used. Quantification of active caspase-3 and the short splice variant of FLICE-inhibitory protein, (FLIP)short, was performed by Western blotting and immunohistochemistry, and cytokines/chemokines were assessed by cytometric bead array or ELISA. M30 immunostaining was done to evaluate epithelial cell apoptosis. Lung injury was assessed on the basis of myeloperoxidase activity, bronchoalveolar lavage protein, and lung histology.
MEASUREMENTS AND MAIN RESULTS: Twelve hours after insult, lung monocyte chemoattractant protein-1, keratinocyte-derived chemokine, macrophage inflammatory protein-2, IL-6, tumor necrosis factor-alpha, and caspase-3 were increased and FLIP(short) was decreased. Fas- and Fas ligand-deficient mice showed marked protection from lung inflammation and apoptosis and decreased ALI. This was associated with a 10-day survival benefit. Similarly, 4 hours after pulmonary instillation of Fas-activating antibody in vivo, lung chemokines were markedly elevated in background mice and, interestingly, to a similar degree in macrophage-deficient animals. Fas activation on lung epithelial cells in vitro led to chemokine production that was dependent on extracellular signal-regulated kinase.
CONCLUSIONS: Activation of apoptotic and nonapoptotic/inflammatory Fas signaling is an early important pathophysiological event in the development of indirect ALI after hemorrhagic shock and sepsis, in which lung epithelial cells appear to play a central role.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600273      PMCID: PMC1994224          DOI: 10.1164/rccm.200611-1743OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  57 in total

Review 1.  Time to change diagnostic criteria of ARDS: towards the disease entity-based subgrouping.

Authors:  Shinhiro Takeda; Akitoshi Ishizaka; Yuji Fujino; Toshio Fukuoka; Osamu Nagano; Yoshitsugu Yamada; Jun Takezawa
Journal:  Pulm Pharmacol Ther       Date:  2005       Impact factor: 3.410

2.  Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes.

Authors:  E C Lerner; Y Qian; M A Blaskovich; R D Fossum; A Vogt; J Sun; A D Cox; C J Der; A D Hamilton; S M Sebti
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

3.  The potential role of BAX and BCL-2 expression in diffuse alveolar damage.

Authors:  D Guinee; E Brambilla; M Fleming; T Hayashi; M Rahn; M Koss; V Ferrans; W Travis
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  Antitumor effect of locally produced CD95 ligand.

Authors:  K Seino; N Kayagaki; K Okumura; H Yagita
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

5.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.

Authors:  V A Fadok; D L Bratton; A Konowal; P W Freed; J Y Westcott; P M Henson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

6.  Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome.

Authors:  S Hashimoto; A Kobayashi; K Kooguchi; Y Kitamura; H Onodera; H Nakajima
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

7.  Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury.

Authors:  R H Bardales; S S Xie; R F Schaefer; S M Hsu
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

8.  Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?

Authors:  L Gattinoni; P Pelosi; P M Suter; A Pedoto; P Vercesi; A Lissoni
Journal:  Am J Respir Crit Care Med       Date:  1998-07       Impact factor: 21.405

9.  CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice.

Authors:  Joanne L Lomas-Neira; Chun-Shiang Chung; Patricia S Grutkoski; Edmund J Miller; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2004-05-03       Impact factor: 4.962

10.  Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion.

Authors:  J Sun; Y Qian; A D Hamilton; S M Sebti
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

View more
  67 in total

1.  Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.

Authors:  Muhuo Ji; Renqi Li; Guo-min Li; Yunxia Fan; Lin Dong; Jianjun Yang; Yong G Peng; Jing Wu
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury.

Authors:  Anne B Lipke; Gustavo Matute-Bello; Raquel Herrero; Venus A Wong; Stephen M Mongovin; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

3.  The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region.

Authors:  Raquel Herrero; Osamu Kajikawa; Gustavo Matute-Bello; Yi Wang; Naoki Hagimoto; Steve Mongovin; Venus Wong; David R Park; Nathan Brot; Jay W Heinecke; Henry Rosen; Richard B Goodman; Xiaoyun Fu; Thomas R Martin
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

Review 4.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

5.  Herpes Virus Entry Mediator (HVEM) Expression Promotes Inflammation/ Organ Injury in Response to Experimental Indirect-Acute Lung Injury.

Authors:  Tingting Cheng; Jianwen Bai; Chun-Shiang Chung; Yaping Chen; Eleanor A Fallon; Alfred Ayala
Journal:  Shock       Date:  2019-04       Impact factor: 3.454

6.  Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury.

Authors:  William J Janssen; Lea Barthel; Alaina Muldrow; Rebecca E Oberley-Deegan; Mark T Kearns; Claudia Jakubzick; Peter M Henson
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

7.  Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock.

Authors:  Ranjit S Chima; Paul W Hake; Giovanna Piraino; Prajakta Mangeshkar; Michael O'Connor; Basilia Zingarelli
Journal:  Int J Clin Exp Med       Date:  2010-01-01

8.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Cl-Amidine Prevents Histone 3 Citrullination and Neutrophil Extracellular Trap Formation, and Improves Survival in a Murine Sepsis Model.

Authors:  Bethany M Biron; Chun-Shiang Chung; Xian M O'Brien; Yaping Chen; Jonathan S Reichner; Alfred Ayala
Journal:  J Innate Immun       Date:  2016-09-14       Impact factor: 7.349

10.  Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages.

Authors:  Feng Wang; Ziyue Lu; Michael Hawkes; Huan Yang; Kevin C Kain; W Conrad Liles
Journal:  J Inflamm (Lond)       Date:  2010-06-17       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.